Elvitegravir Patent Expiration
Elvitegravir is Used for managing HIV infection. It was first introduced by Gilead Sciences Inc
Elvitegravir Patents
Given below is the list of patents protecting Elvitegravir, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Vitekta | US7176220 | 4-oxoquinoline compound and use thereof as pharmaceutical agent | Aug 27, 2026 | Gilead Sciences Inc |
| Vitekta |
US7176220 (Pediatric) | 4-oxoquinoline compound and use thereof as pharmaceutical agent | Feb 27, 2027 | Gilead Sciences Inc |
| Vitekta | US7635704 | Stable crystal of 4-oxoquinoline compound | Oct 26, 2026 | Gilead Sciences Inc |
| Vitekta |
US7635704 (Pediatric) | Stable crystal of 4-oxoquinoline compound | Apr 26, 2027 | Gilead Sciences Inc |
| Vitekta | US8981103 | Stable crystal of 4-oxoquinoline compound | Oct 26, 2026 | Gilead Sciences Inc |
| Vitekta |
US8981103 (Pediatric) | Stable crystal of 4-oxoquinoline compound | Apr 26, 2027 | Gilead Sciences Inc |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳